Theodora Harold was appointed CEO of Crescendo Biologics (Crescendo) in May 2019. She joined the Company in 2016 and was promoted to CEO, having previously held both CFO and CBO roles. She has over 20 years’ experience with both private and listed biotech SMEs and to date she has helped raise almost $200m for the sector. She was on the founding teams of both MISSION Therapeutics and PsiOxus Therapeutics where she was CFO, as well as having held executive roles with companies such as Cytomyx Holdings Plc and Orthomimetics. Theodora qualified as Chartered Accountant with PricewaterhouseCoopers and read Classics at Trinity College, Cambridge.